Increased Expression of MicroRNA-206 Inhibits Potassium Voltage-Gated Channel Subfamily A Member 5 in Pulmonary Arterial Smooth Muscle Cells and Is Related to Exaggerated Pulmonary Artery Hypertension Following Intrauterine Growth Retardation in Rats

被引:26
作者
Lv, Ying [1 ]
Fu, Linchen [2 ]
Zhang, Ziming [2 ]
Gu, Weizhong [2 ]
Luo, Xiaofei [2 ]
Zhong, Ying [2 ]
Xu, Shanshan [2 ]
Wang, Yu [2 ]
Yan, Lingling [2 ]
Li, Min [2 ]
Du, Lizhong [2 ]
机构
[1] Zhejiang Univ, Childrens Hosp, Sch Med, Dept Pediat Hlth Care, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ, Childrens Hosp, Sch Med, Dept Neonatol, Hangzhou, Zhejiang, Peoples R China
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2019年 / 8卷 / 02期
基金
中国国家自然科学基金;
关键词
epigenetics; K-channel; Kv1.5; microRNA; microRNA-206; PAH; PASMCs; pulmonary hypertension; HYPOXIA; GENE; VASOCONSTRICTION; ANTAGONIST; RECEPTOR; TARGET;
D O I
10.1161/JAHA.118.010456
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Intrauterine growth retardation (IUGR) is related to pulmonary artery hypertension in adults, and microRNA-206 (miR-206) is proposed to affect the proliferation and apoptosis of pulmonary artery smooth muscle cells (PASMCs) via post transcriptional regulation. Methods and Results In an IUGR rat model, we found that the expression and function of potassium voltage-gated channel subfamily A member 5 (Kv1.5) in PASMCs was inhibited, and pulmonary artery hypertension was exaggerated after chronic hypoxia (CH) treatment as adults. microRNA expression was investigated in PASMCs from 12-week-old male IUGR rats with CH by microarray, polymerase chain reaction, and in situ hybridization. The expression levels of Kv1.5 in primary cultured PASMCs and pulmonary artery smooth muscle from IUGR or control rats were evaluated with and without application of an miR-206 inhibitor. Right ventricular systolic pressure, cell proliferation, luciferase reporter assay, and /(kv) wee also calculated. We found increased expression of miR-206 in resistance pulmonary arteries of IUGR rats at 12 weeks compared with newborns. Application of an miR-06 inhibitor in vivo or in vitro increased expression of Kv1.5 alpha-protein and KCNA5. Also, decreased right ventricular systolic pressure and cell proliferation were observed in PASMCs from 12-week-old control and IUGR rats after CH, while inhibitor did not significantly affect control and IUGR rats. Conclusions These results suggest that expression of Kvl.5 and 4-aminopyridine (Kv channel special inhibitor)-sensitive Kv current were correlated with the inhibition of miR-206 in PA rings of IUGR-CH rats and cultured IUGR PASMCs exposed to hypoxia. Thus, miR-206 may be a trigger for induction of exaggerated CH pulmonary artery hypertension of IUGR via Kv1.5.
引用
收藏
页数:13
相关论文
共 32 条
  • [1] Preferential expression and function of voltage-gated, O2-sensitive K+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction -: Ionic diversity in smooth muscle cells
    Archer, SL
    Wu, XC
    Thébaud, B
    Nsair, A
    Bonnet, S
    Tyrrell, B
    McMurtry, MS
    Hashimoto, K
    Harry, G
    Michelakis, ED
    [J]. CIRCULATION RESEARCH, 2004, 95 (03) : 308 - 318
  • [2] The developmental origins of chronic adult disease
    Barker, DJP
    [J]. ACTA PAEDIATRICA, 2004, 93 : 26 - 33
  • [3] MicroRNAs in pulmonary arterial hypertension: pathogenesis, diagnosis and treatment
    Bienertova-Vasku, Julie
    Novak, Jan
    Vasku, Anna
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2015, 9 (03) : 221 - 234
  • [4] Dynamic Changes in Lung MicroRNA Profiles During the Development of Pulmonary Hypertension due to Chronic Hypoxia and Monocrotaline
    Caruso, Paola
    MacLean, Margaret R.
    Khanin, Raya
    McClure, John
    Soon, Elaine
    Southgate, Mark
    MacDonald, Robert A.
    Greig, Jenny A.
    Robertson, Keith E.
    Masson, Rachel
    Denby, Laura
    Dempsie, Yvonne
    Long, Lu
    Morrell, Nicholas W.
    Baker, Andrew H.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (04) : 716 - U182
  • [5] MiR-206 Controls the Phenotypic Modulation of Pulmonary Arterial Smooth Muscle Cells Induced by Serum from Rats with Hepatopulmonary Syndrome by Regulating the Target Gene, Annexin A2
    Chen, Lin
    Li, Yong-shuai
    Cui, Jian
    Ning, Jiao-nin
    Wang, Guan-song
    Qian, Gui-sheng
    Lu, Kai-zhi
    Yi, Bin
    [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2014, 34 (05) : 1768 - 1779
  • [6] Role for miR-204 in human pulmonary arterial hypertension
    Courboulin, Audrey
    Paulin, Roxane
    Giguere, Nellie J.
    Saksouk, Nehme
    Perreault, Tanya
    Meloche, Jolyane
    Paquet, Eric R.
    Biardel, Sabrina
    Provencher, Steeve
    Cote, Jacques
    Simard, Martin J.
    Bonnet, Sebastien
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (03) : 535 - 548
  • [7] MicroRNAs and endocrine biology
    Cuellar, TL
    McManus, MT
    [J]. JOURNAL OF ENDOCRINOLOGY, 2005, 187 (03) : 327 - 332
  • [8] Lung microRNA deregulation associated with impaired alveolarization in rats after intrauterine growth restriction
    Dravet-Gounot, Pauline
    Morin, Cecile
    Jacques, Sebastien
    Dumont, Florent
    Ely-Marius, Fabiola
    Vaiman, Daniel
    Jarreau, Pierre-Henri
    Mehats, Celine
    Zana-Taieb, Elodie
    [J]. PLOS ONE, 2017, 12 (12):
  • [9] Quantitative immunofluorescent blotting of the Multidrug Resistance-associated Protein 2 (MRP2)
    Gerk, Phillip M.
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2011, 63 (03) : 279 - 282
  • [10] Recent progress toward the use of circulating microRNAs as clinical biomarkers
    Ghai, Vikas
    Wang, Kai
    [J]. ARCHIVES OF TOXICOLOGY, 2016, 90 (12) : 2959 - 2978